News
19h
TipRanks on MSNGSK’s Promising Study on Belimumab for Lung Disease: What Investors Need to KnowGlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
2d
TipRanks on MSNGSK’s Promising Study on Belimumab for Systemic Sclerosis Lung DiseaseGlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
Individuals with vs. without interstitial lung disease faced an elevated risk for lung cancer and histological subtypes of lung cancer in adjusted and sibling-controlled analyses, according to results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results